Last updated on April 18, 2014 at 16:58 EDT

Latest Non-mycosis fungoides CD30− cutaneous large T-cell lymphoma Stories

2012-07-09 02:24:27

SAN DIEGO, July 9, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announces it has received Investigational Review Board (IRB) approval at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center for a Phase II clinical trial evaluating OncoSec's OMS ElectroImmunotherapy for the treatment of cutaneous T-cell...